In Brief: Sulzer Medica AnnuloFlo
This article was originally published in The Gray Sheet
Executive Summary
Sulzer Medica AnnuloFlo: Mitral valve annuloplasty ring system launch is slated for January 1998 following FDA 510(k) clearance, announced Oct. 1. The device represents the firm's entry into the cardiac repair market and complements Sulzer's valve replacement products, the company says. AnnuloFlo is the first annuloplasty ring with an accompanying flexible handle to hold it in place during surgery, allowing for easier implementation and suturing, Sulzer claims...
You may also be interested in...
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.